Evolving diversity in globally circulating HIV-1 subtypes presents formidable challenge in defining and developing neutralizing antibodies for prevention and treatment. HIV-1 subtype C is responsible for majority of global HIV-1 infections. Broadly neutralizing antibodies (bnAbs) capable of neutralizing distinct HIV-1 subtypes by targeting conserved vulnerable epitopes on viral envelope protein (Env) are being considered as promising antiviral agents for prevention and treatment. In the present study, we examined the diversity in genetic signatures and attributes that differentiate region-specific global HIV-1 subtype C gp120 sequences associated with virus neutralization outcomes to key bnAbs having distinct epitope specificities. A total of 1814 full length HIV-1 subtype C gp120 sequence from 37 countries were retrieved from Los Alamos National Laboratory HIV database (www.hiv.lanl.gov). The amino acid sequences were assessed for their phylogenetic association, variable loop lengths and prevalence of potential N-linked glycosylation sites (pNLGS). Responses of these sequences to bnAbs were predicted with a machine learning algorithm ‘bNAb-ReP’ and compared with those reported in the CATNAP database. Phylogenetically, sequences from Asian countries including India clustered together however differed significantly when compared with pan African subtype C sequences. Variable loop lengths within Indian and African clusters were distinct from each other, specifically V1, V2 and V4 loops. Furthermore, V1V2 and V2 alone sequences were also found to vary significantly in their charges. Pairwise analyses at each of the 25 pNLG sites indicated distinct country specific profiles. Highly significant differences (p<0.001***) were observed in prevalence of four pNLGS (N130, N295, N392 and N448) between South Africa and India, having most disease burden associated with subtype C. Our findings highlight that the distinctly evolving clusters within global intra-subtype C gp120 sequences are likely to influence the disparate regionspecific sensitivity of circulating HIV-1 subtype C to bnAbs.Author SummaryBroadly neutralizing antibodies (bnAbs) that act on viral envelope protein and prevent establishment of infection have emerged as an attractive choice for HIV-1 treatment and prophylaxis over and above existing antiretroviral drug therapy. While HIV-1 subtype C accounts for nearly half of the global infection, the degree of intra-clade C variability across different geographical boundaries with particular reference to env gene (which is the target of neutralizing antibodies) is poorly understood. Through a systematic approach and by applying standardized computational algorithms, we carried out comprehensive comparison of the genetic properties of the gp120 sequences that represent globally circulating HIV-1 subtype C towards accurately predicating their degree of susceptibility to most broad and potent neutralizing monoclonal antibodies having different target specificities across gp120. Our data not only revealed significant intra-clade C diversity but also highlighted neutralization diversities. These observations provide insights that warrant greater and continued surveillance of evolving HIV-1 globally circulating subtype C variants that will inform selection of bnAbs that will best dissect the region-specific genetic and neutralization diversities towards selecting appropriate bnAb combination for clinical use.